Literature DB >> 20508205

Role of heme oxygenase-1 in human endothelial cells: lesson from the promoter allelic variants.

Hevidar Taha1, Klaudia Skrzypek, Ibeth Guevara, Anneliese Nigisch, Stefan Mustafa, Anna Grochot-Przeczek, Pawel Ferdek, Halina Was, Jerzy Kotlinowski, Magdalena Kozakowska, Aneta Balcerczyk, Lucie Muchova, Libor Vitek, Guenter Weigel, Jozef Dulak, Alicja Jozkowicz.   

Abstract

OBJECTIVE: Heme oxygenase-1 (HO-1) is an antioxidative, antiinflammatory, and cytoprotective enzyme that is induced in response to cellular stress. The HO-1 promoter contains a (GT)n microsatellite DNA, and the number of GT repeats can influence the occurrence of cardiovascular diseases. We elucidated the effect of this polymorphism on endothelial cells isolated from newborns of different genotypes. METHODS AND
RESULTS: On the basis of HO-1 expression, we classified the HO-1 promoter alleles into 3 groups: short (S) (most active, GT < or = 23), medium (moderately active, GT=24 to 28), and long (least active, GT > or = 29). The presence of the S allele led to higher basal HO-1 expression and stronger induction in response to cobalt protoporphyrin, prostaglandin-J(2), hydrogen peroxide, and lipopolysaccharide. Cells carrying the S allele survived better under oxidative stress, a fact associated with the lower concentration of oxidized glutathione and more favorable oxidative status, as determined by measurement of the ratio of glutathione to oxidized glutathione. Moreover, they proliferated more efficiently in response to vascular endothelial growth factor A, although the vascular endothelial growth factor-induced migration and sprouting of capillaries were not influenced. Finally, the presence of the S allele was associated with lower production of some proinflammatory mediators, such as interleukin-1beta, interleukin-6, and soluble intercellular adhesion molecule-1.
CONCLUSIONS: The (GT)n promoter polymorphism significantly modulates a cytoprotective, proangiogenic, and antiinflammatory function of HO-1 in human endothelium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20508205      PMCID: PMC2906705          DOI: 10.1161/ATVBAHA.110.207316

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  44 in total

1.  Repression of heme oxygenase-1 expression as a defense strategy in humans.

Authors:  Shigeki Shibahara; Masaharu Nakayama; Tomomi Kitamuro; Reiko Udono-Fujimori; Kazuhiro Takahashi
Journal:  Exp Biol Med (Maywood)       Date:  2003-05

2.  Heme oxygenase and angiogenic activity of endothelial cells: stimulation by carbon monoxide and inhibition by tin protoporphyrin-IX.

Authors:  Alicja Józkowicz; Ihor Huk; Anneliese Nigisch; Guenter Weigel; Wolf Dietrich; Roberto Motterlini; Józef Dulak
Journal:  Antioxid Redox Signal       Date:  2003-04       Impact factor: 8.401

3.  Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting.

Authors:  Ying-Hwa Chen; Lee-Young Chau; Ming-Wei Lin; Lung-Ching Chen; Ming-Hui Yo; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Eur Heart J       Date:  2004-01       Impact factor: 29.983

4.  Microsatellite polymorphism in heme oxygenase-1 gene promoter is associated with susceptibility to oxidant-induced apoptosis in lymphoblastoid cell lines.

Authors:  Hisao Hirai; Hiroshi Kubo; Mutsuo Yamaya; Katsutoshi Nakayama; Muneo Numasaki; Seiichi Kobayashi; Satoshi Suzuki; Shigeki Shibahara; Hidetada Sasaki
Journal:  Blood       Date:  2003-05-01       Impact factor: 22.113

5.  Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse.

Authors:  Matthias H Kapturczak; Clive Wasserfall; Todd Brusko; Martha Campbell-Thompson; Tamir M Ellis; Mark A Atkinson; Anupam Agarwal
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  The effect of a promoter polymorphism in the heme oxygenase-1 gene on the risk of ischaemic cerebrovascular events: the influence of other vascular risk factors.

Authors:  Marion Funk; Georg Endler; Martin Schillinger; Stefan Mustafa; Kety Hsieh; Markus Exner; Wolfgang Lalouschek; Christine Mannhalter; Oswald Wagner
Journal:  Thromb Res       Date:  2004       Impact factor: 3.944

7.  Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients.

Authors:  Ying-Hwa Chen; Shing-Jong Lin; Ming-Wei Lin; Hui-Ling Tsai; San-San Kuo; Jaw-Wen Chen; Min-Ji Charng; Tao-Cheng Wu; Lung-Ching Chen; Yu-An Ding; Wen-Harn Pan; Yuh-Shan Jou; Lee-Young Chau
Journal:  Hum Genet       Date:  2002-06-19       Impact factor: 4.132

Review 8.  The story so far: Molecular regulation of the heme oxygenase-1 gene in renal injury.

Authors:  Eric M Sikorski; Thomas Hock; Nathalie Hill-Kapturczak; Anupam Agarwal
Journal:  Am J Physiol Renal Physiol       Date:  2004-03

9.  Stress protein activation by the cyclopentenone prostaglandin 15-deoxy-delta12,14-prostaglandin J2 in human mesangial cells.

Authors:  Xiaolan Zhang; Ling Lu; Cynthia Dixon; William Wilmer; Huijuan Song; Xilin Chen; Brad H Rovin
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

10.  Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling.

Authors:  Shaw-Fang Yet; Matthew D Layne; Xiaoli Liu; Yen-Hsu Chen; Bonna Ith; Nicholas E S Sibinga; Mark A Perrella
Journal:  FASEB J       Date:  2003-07-03       Impact factor: 5.191

View more
  40 in total

1.  Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization.

Authors:  Anna Grochot-Przeczek; Jerzy Kotlinowski; Magdalena Kozakowska; Katarzyna Starowicz; Jolanta Jagodzinska; Anna Stachurska; Oscar L Volger; Karolina Bukowska-Strakova; Urszula Florczyk; Magdalena Tertil; Agnieszka Jazwa; Krzysztof Szade; Jacek Stepniewski; Agnieszka Loboda; Anton J G Horrevoets; Jozef Dulak; Alicja Jozkowicz
Journal:  Antioxid Redox Signal       Date:  2014-02-28       Impact factor: 8.401

2.  Network for activation of human endothelial cells by oxidized phospholipids: a critical role of heme oxygenase 1.

Authors:  Casey E Romanoski; Nam Che; Fen Yin; Nguyen Mai; Delila Pouldar; Mete Civelek; Calvin Pan; Sangderk Lee; Ladan Vakili; Wen-Pin Yang; Paul Kayne; Imran N Mungrue; Jesus A Araujo; Judith A Berliner; Aldons J Lusis
Journal:  Circ Res       Date:  2011-07-07       Impact factor: 17.367

3.  Heme Oxygenase-1 Gene Polymorphisms-Toward Precision Medicine for AKI.

Authors:  Lisa M Curtis; Anupam Agarwal
Journal:  J Am Soc Nephrol       Date:  2016-08-04       Impact factor: 10.121

Review 4.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

5.  Murine Bone Marrow Mesenchymal Stromal Cells Respond Efficiently to Oxidative Stress Despite the Low Level of Heme Oxygenases 1 and 2.

Authors:  Witold Norbert Nowak; Hevidar Taha; Neli Kachamakova-Trojanowska; Jacek Stępniewski; Joanna Agata Markiewicz; Anna Kusienicka; Krzysztof Szade; Agata Szade; Karolina Bukowska-Strakova; Karolina Hajduk; Damian Klóska; Aleksandra Kopacz; Anna Grochot-Przęczek; Kathrin Barthenheier; Camille Cauvin; Józef Dulak; Alicja Józkowicz
Journal:  Antioxid Redox Signal       Date:  2018-01-03       Impact factor: 8.401

6.  Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis.

Authors:  Klaudia Skrzypek; Magdalena Tertil; Slawomir Golda; Maciej Ciesla; Kazimierz Weglarczyk; Guillaume Collet; Alan Guichard; Magdalena Kozakowska; Jorge Boczkowski; Halina Was; Tomasz Gil; Jaroslaw Kuzdzal; Lucie Muchova; Libor Vitek; Agnieszka Loboda; Alicja Jozkowicz; Claudine Kieda; Jozef Dulak
Journal:  Antioxid Redox Signal       Date:  2013-06-27       Impact factor: 8.401

7.  Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter.

Authors:  Yohann Repessé; Ivan Peyron; Jordan D Dimitrov; Suryasarathi Dasgupta; Elika Farrokhi Moshai; Catherine Costa; Annie Borel-Derlon; Benoit Guillet; Roseline D'Oiron; Achille Aouba; Chantal Rothschild; Johannes Oldenburg; Anna Pavlova; Srinivas V Kaveri; Sébastien Lacroix-Desmazes
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

8.  Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

Authors:  Christopher J Bean; Sheree L Boulet; Dorothy Ellingsen; Meredith E Pyle; Emily A Barron-Casella; James F Casella; Amanda B Payne; Jennifer Driggers; Heidi A Trau; Genyan Yang; Kimberly Jones; Solomon F Ofori-Acquah; W Craig Hooper; Michael R DeBaun
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

9.  Increased risk of venous thromboembolism is associated with genetic variation in heme oxygenase-1 in Blacks.

Authors:  Christopher J Bean; Sheree L Boulet; Dorothy Ellingsen; Heidi Trau; Nafisa Ghaji; W Craig Hooper; Harland Austin
Journal:  Thromb Res       Date:  2012-09-07       Impact factor: 3.944

Review 10.  New insights into intracellular locations and functions of heme oxygenase-1.

Authors:  Louise L Dunn; Robyn G Midwinter; Jun Ni; Hafizah A Hamid; Christopher R Parish; Roland Stocker
Journal:  Antioxid Redox Signal       Date:  2014-02-28       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.